IGC PHARMA, INC. Goodwill, Acquired During Period
IGC PHARMA, INC. (IGC) reported Goodwill, Acquired During Period of $982.78 thousand for the 9-month period ending 2015-12-31, per its 10-Q filed 2016-02-16.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2016-02-16
- IGC PHARMA, INC. goodwill, acquired during period for the quarter ending 2015-12-31 was $0.00.
- IGC PHARMA, INC. goodwill, acquired during period for the quarter ending 2015-09-30 was $0.00.
- IGC PHARMA, INC. goodwill, acquired during period for the quarter ending 2015-06-30 was $982.78K, a 0.00% change year-over-year.
- IGC PHARMA, INC. goodwill, acquired during period for the quarter ending 2015-03-31 was $0.00.
- IGC PHARMA, INC. goodwill, acquired during period for fiscal 2014 was $0.00.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $0.00 derived: sum of 2 quarters · filed 2016-02-16 | $982.78K 10-Q · filed 2016-02-16 | $982.78K derived: sum of 4 quarters · filed 2016-02-16 |
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-13 | $982.78K 10-Q · filed 2015-11-13 | $982.78K derived: sum of 3 quarters · filed 2016-02-16 | $982.78K derived: sum of 4 quarters · filed 2016-02-16 |
| 2015-06-30 | $982.78K 10-Q · filed 2015-08-14 | $982.78K derived: sum of 2 quarters · filed 2016-02-16 | $982.78K derived: sum of 3 quarters · filed 2016-02-16 | $982.78K derived: sum of 4 quarters · filed 2016-02-16 |
| 2015-03-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2016-02-16 | $0.00 derived: sum of 2 quarters · filed 2016-02-16 | $0.00 derived: sum of 3 quarters · filed 2016-02-16 | $982.78K 10-Q · filed 2016-02-16 |
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | $0.00 derived: sum of 2 quarters · filed 2015-02-12 | $982.78K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $982.78K 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | $982.78K 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | $0.00 10-K · filed 2015-07-14 | |||
| 2012-12-31 | $0.00 10-Q · filed 2013-02-13 | |||
| 2012-03-31 | $643.12K 10-Q · filed 2013-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |